SEC Form 4 · accession 0001682852-26-000161
Moderna, Inc. · MRNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Hoge
Officer — President
Period of report
Aug 27, 2026
Accepted (ET)
Aug 31, 2026 · 4:51 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001682852
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 27, 2026 | M | 1,437 | — | A | 1,485,285 | D | |
| Common Stock | Aug 27, 2026 | F | 695 | $149.66 | D | 1,484,590 | D | |
| Common StockF1 | Aug 28, 2026 | M | 611 | — | A | 1,485,201 | D | |
| Common Stock | Aug 28, 2026 | F | 296 | $142.77 | D | 1,484,905 | D | |
| Common Stock | holding | — | — | — | 4,116 | I | By Valhalla, LLC | |
| Common StockF3 | holding | — | — | — | 151,933 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F4 | — | Aug 27, 2026 | M | 1,437 | D | — | — | Common Stock | 1,437 | 8,621 | D |
| Restricted Stock UnitsF1,F5 | — | Aug 28, 2026 | M | 611 | D | — | — | Common Stock | 611 | 1,221 | D |
Explanation of responses
- F1Restricted stock units convert into common stock on a one-for-one basis.
- F2Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
- F3These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
- F425% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- F525% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.